Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. advanced 9.9% to $59.17 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.

The stock's rise snapped a two-day losing streak.

Moderna Inc. closed 30.9% short of its 52-week high of $85.60, which the company reached on July 6th.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $259.24, Pfizer Inc. rose 2.1% to $26.76, and Gilead Sciences Inc. rose 1.80% to $133.21.

Trading volume totaled 6.8 million, compared to the 50-day average of 7.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 07, 2026 16:33 ET (20:33 GMT)